tldrdailynews.com logo

ARPA-H funds on-demand, patient-specific RNA medicines with $125M grant

1 min read
Source: Endpoints News
ARPA-H funds on-demand, patient-specific RNA medicines with $125M grant
Photo: Endpoints News
TL;DR Summary

The U.S. ARPA-H is awarding $125 million to enable the rapid, on-demand production of personalized RNA-based therapies, accelerating the development of patient-specific genetic medicines; five groups have been selected for funding.

Topics:business#arpa-h#biotech-funding#on-demand-manufacturing#personalized-medicine#rna-therapies#science
Share this article
  1. ARPA-H awards $125M for manufacturing custom RNA therapies on demand  Endpoints News
  2. ARPA-H funds biotechs working on custom RNA therapies  STAT
  3. US puts $125m into personalised RNA therapy production  pharmaphorum
  4. ARPA-H backs five teams with $125m to make RNA meds on demand  The Pharma Letter
  5. Waterfall Scientific Awarded $54.5 Mln To Lead Consortium For Cell-Free mRNA Manufacturing  TradingView

Reading Insights

Total Reads

0

Unique Readers

6

Time Saved

0 min

vs 1 min read

Condensed

63%

83 → 31 words

Want the full story? Read the original article

Read on Endpoints News